CVS Health Corporation (NYSE: CVS) Stock Rating Reiterated at Credit Suisse Group AG

CVS Health Corporation (NYSE: CVS) had its Buy rating reiterated by equities researchers at Credit Suisse Group AG in a research note to investors. The company currently has a rating of Buy on the shares. A number of other analysts have commented on the stock in recent days, and CVS Health Corporation has earned a consensus one-year price target of $111.07, higher than the opening price of $89.50. CVS Health Corporation stock has a 52-week high of $106.67. Usually, after analysts give a “reiterated rating” report on a stock, they will subsequently issue sporadic revisions, usually followed by a price target change.

U.S. stocks on Monday closed mostly flat, after trading firmly higher, in a volatile session ahead of the start of a pair of closely watched central-bank policy meetings.

The Dow Jones Industrial Average DJIA, -0.02% closed down 3.63 points at 18,120.17.

The blue-chip index had been up by as much as 131 points earlier and traded within a 162-point range.

The S&P 500 SPX, +0.00% slipped 0.04 points to close at 2,139.12, after trading within an 18-point range

Meanwhile, the Nasdaq Composite Index COMP, -0.18% declined 9.54 points, or 0.2%, to close at 5,235.03.

Earlier, the index had been up by as many as 37 points and traded with a 58-point range

Shares of CVS Health Corporation (NYSE: CVS) opened at $89.50 yesterday and traded in a range between, $89.50 and $90.10, and last traded at $89.99, an increase of $0.82 compared to the previous closing price.

CVS Health Corporation (NYSE: CVS) now has a market cap of 95.94B.

1,397,218 shares traded hands yesterday, 61 percent lower than the average, out of a total float 1,064,434,000. Trading volume is likely to increase in the next few days as investors often use increases in trading volume to determine heavy volume aggregation or circulation by institutional investors.

However, a single day of heavy buy side trading is not enough to assert a trend. As such, market traders will continue to look for institutional sponsorship as a cue that financial institutions are moving forward.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These instituitional investors retain substantial teams of analysts that investigate thousands of stocks. So watching their interests is a good way to ensure you are buying the right stocks.

Traders are able to make make educated trades when they follow the activity of professional investors.

With that in mind, CVS Health Corporation (NYSE: CVS) now has a 50-day MA of $94.74 and 200-day MA of $98.04. It has traded in a 52-week range between $86.50 – 106.670 and today’s last price is 0.16% lower than the 52 week high of $106.67.

Indeed, earnings growth is among the most crucial things to look at in regards to stock investing and, accordingly, investors look for companies that have been successful at growing their earnings at least 25% or more for the past 3 years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Add a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.